🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta

Recruitingn/aAges 12 Years - 20 YearsAllAssistance Publique - Hôpitaux de Paris
NCT05419960 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim is to determine whether vestibular deficits are present in OI, then to establish whether a correlation exists between genetic type, severity of OI and audiovestibular phenotype. OI patients aged 12 to 20 years will undergo an audiometric, immittance, and vestibular assessment. When hearing loss is conductive or mixed or in cases where vestibular deficits are identified, a CT scan without injection will be performed. In case of sensorineural hearing loss or abnormal CT results, an MRI will be performed.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients between the ages of 12-20 years at the time of inclusion * Diagnosis of Osteogenesis Imperfecta of any type * Currently followed by a physician at the CRMR OI * Information and non-opposition of major patients, holders of parental authority and minor patients to participate in the study Exclusion Criteria: * Patients with hearing loss of alternate origin e.g. Cochlear nerve deficiency, atresia, etc. * Neurological or developmental deficits limiting participation * Cervico-occipital instability e.g. Chiari's malformation * Limitations in mobility of the spine e.g. scoliosis, spinal fractural fusion * Ophthalmologic pathologies e.g. strabism or severe refraction disorder * Patients under AME (State Medical Aid) * Protected adult patients, adults unable to express their consent, pregnant or breastfeeding women
💊

What it tests

  • Vestibular Assessment
  • Petrous bone Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
📍

Where

1 site
Hôpital Necker-Enfants Malades
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy